Kevin P Foley

US Patent:

8063083, Nov 22, 2011

Filed:

May 25, 2007

Appl. No.:

11/807199

Inventors:

Kevin Foley - Waltham MA, US

Assignee:

Synta Pharmaceuticals Corp. - Lexington MA

International Classification:

A61K 31/4196
A61P 35/00

US Classification:

514383

Abstract:

The present invention relates to methods of inhibiting the activity of Hsp90 in a subject in need thereof and methods for treating non-Hodgkin's lymphoma, in a subject in need thereof.

US Patent:

8183384, May 22, 2012

Filed:

May 25, 2007

Appl. No.:

11/807331

Inventors:

Dinesh U. Chimmanamada - Arlington MA, US
Weiwen Ying - Ayer MA, US
Teresa Przewloka - Tewksbury MA, US
Shijie Zhang - Nashua NH, US
Kevin Foley - Waltham MA, US
Zhenjian Du - Northborough MA, US
Dan Zhou - Lexington MA, US
Shuzhen Qin - West Roxbury MA, US

Assignee:

Synta Pharmaceuticals Corp. - Lexington MA

International Classification:

C07D 249/12
A61K 31/4196

US Classification:

5482632, 514384

Abstract:

The present invention relates to substituted triazole compounds and compositions comprising substituted triazole compounds. The invention further relates to methods of inhibiting the activity of Hsp90 in a subject in need thereof and methods for preventing or treating hyperproliferative disorders, such as cancer, in a subject in need thereof comprising administering to the subject a substituted triazole compound of the invention, or a composition comprising such a compound.

US Patent:

8329736, Dec 11, 2012

Filed:

Apr 20, 2012

Appl. No.:

13/452200

Inventors:

Dinesh U. Chimmanamada - Arlington MA, US
Weiwen Ying - Ayer MA, US
Teresa Kowalczyk Przewloka - Tewksbury MA, US
Shijie Zhang - Nashua NH, US
Kevin Foley - Waltham MA, US
Zhenjian Du - Northborough MA, US
Dan Zhou - Lexington MA, US
Shuzhen Qin - West Roxbury MA, US

Assignee:

Synta Pharmaceuticals, Corp. - Lexington MA

International Classification:

A61K 31/4196
C07D 249/12

US Classification:

514384, 5482632

Abstract:

The present invention relates to substituted triazole compounds and compositions comprising substituted triazole compounds. The invention further relates to methods of inhibiting the activity of Hsp90 in a subject in need thereof and methods for preventing or treating hyperproliferative disorders, such as cancer, in a subject in need thereof comprising administering to the subject a substituted triazole compound of the invention, or a composition comprising such a compound.

US Patent:

20030120632, Jun 26, 2003

Filed:

Nov 1, 2002

Appl. No.:

10/285983

Inventors:

Paul Casey - Boston MA, US
James Munz - Watertown MA, US
Kevin Foley - Boston MA, US

International Classification:

G06F007/00

US Classification:

707/001000

Abstract:

A method of programmatically retrieving and processing electronically posted medical bill payments is disclosed. Electronically posted payment information is programmatically retrieved, parsed into a pre-determined format and stored in a permanent database. The information is subsequently retrieved from the database/storage location and reformatted to meet individual medical provider requirements compatible with the medical provider's internal billing systems. The retrieved payment information is used to update the billing records for previously submitted claims from the medical provider. Data is parsed into transaction level, claim level and service level information. Information on denials of payment and partial payments for submitting claims is stored in the permanent database and later utilized to generate Explanation of Benefit report needed to re-submit the medical claims to the same or different medical carrier.

US Patent:

20050203119, Sep 15, 2005

Filed:

Sep 10, 2004

Appl. No.:

10/939252

Inventors:

Mitsunori Ono - Lexington MA, US
Yumiko Wada - Billerica MA, US
Lijun Sun - Harvard MA, US
Shoujun Chen - Bedford MA, US
Teresa Przewloka - Tewksbury MA, US
Shijie Zhang - Nashua NH, US
Christopher Borella - Cambridge MA, US
Keizo Koya - Chestnut Hill MA, US
Kevin Foley - Cambridge MA, US
Zhi-Qiang Xia - Acton MA, US
Hao Li - Brookline MA, US
Dan Zhou - Lexington MA, US

International Classification:

C07D471/02
C07D491/02
C07D498/02
A61K031/4745
A61K031/4743
A61K031/4741
A61K031/47

US Classification:

514300000, 546178000, 546122000, 546115000, 546114000, 514311000, 514302000, 514301000

Abstract:

This invention relates to dihydropyridine compounds of formula (I): or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof wherein A, R, R, R, R, R, R, R, R, R, R, R, and m are defined herein, and compositions comprising such compounds. The invention also relates to methods of preventing or treating metabolic disorders, such as diabetes mellitus, and conditions and complications associated with diabetes mellitus, comprising administering to a subject in need thereof a compound of formula (1) or a composition comprising such a compound. The invention further relates to kits comprising a compound of formula (I).

US Patent:

20070032493, Feb 8, 2007

Filed:

May 26, 2006

Appl. No.:

11/442744

Inventors:

Kevin Foley - Waltham MA, US
John Bertin - Winchester MA, US
Ethan Grant - Morristown NJ, US

Assignee:

Synta Pharmaceuticals Corp. - Lexington MA

International Classification:

A61K 31/506
A61K 31/53

US Classification:

514241000, 514256000

Abstract:

The invention relates to a method for treating B-cell regulated autoimmune disorders using compounds that modulate the activity of c-Rel.

US Patent:

20070048318, Mar 1, 2007

Filed:

Oct 10, 2006

Appl. No.:

11/548017

Inventors:

EMMA MOORE - Seattle WA, US
Kevin Foley - Charlestown MA, US
Karen Madden - Bellevue WA, US
Yue Yao - Kenmore WA, US
Scott Presnell - Tacoma WA, US

International Classification:

A61K 39/395

US Classification:

424145100

Abstract:

A method for treating psoriasis. An antagonist to IL-17Dβ9 (IL-17D) is administered to treat psoriasis. The antagonist can be an antibody that binds to IL-17Dβ9 or its receptor or a soluble receptor that binds to IL-17Dβ9 or a membrane-spanning protein-5 (MSP-5).

US Patent:

20100093670, Apr 15, 2010

Filed:

Sep 13, 2007

Appl. No.:

12/310950

Inventors:

Yaming Wu - Lexington MA, US
Kevin Foley - Waltham MA, US
Christopher Borella - Bedford MA, US

International Classification:

A61K 31/675
A61K 31/42
A61K 31/4192
A61K 31/425

US Classification:

514 93, 514378, 514359, 514372, 514 92

Abstract:

The invention relates to isoxazole, isothiazole, and triazole compounds that are useful for treating or inhibiting angiogenesis.

Address:

2 Homewood Rd, West Roxbury, MA 02132

VIN:

WDDGF8BB2AF443331

Make:

MERCEDES-BENZ

Model:

C-CLASS

Year:

2010